Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?

AIMS Despite advancements over the past years, normal reperfusion at the myocardial level is not achieved in approximately every other patient with ST-elevation myocardial infarction. In the current work, we aimed at reviewing the role of the coronary microcirculation in the development and outcome of this acute coronary syndrome entity. METHODS AND RESULTS A PubMed/Medline search was performed with the key words acute coronary syndrome, acute myocardial infarction, coronary artery disease, endothelial dysfunction, microcirculation, and reperfusion. The synthesis of the information points to myocardial microcirculatory dysfunction as a consequence of a primary epicardial event, based on the vulnerable plaque concept. As an alternative theory, microcirculatory dysfunction may contribute to the clinical course of the acute coronary event, based on the vulnerable patient concept. The pros and cons of these two viewpoints are to be discussed and their influence on patient management is to be considered. CONCLUSION Microcirculatory dysfunction in ST-elevation myocardial infarction can be cause, consequence or both according to non-traditional and traditional concepts.

[1]  G. Gross,et al.  Reperfusion injury: does it exist? , 2007, Journal of molecular and cellular cardiology.

[2]  Renu Virmani,et al.  Pathology of the vulnerable plaque. , 2007, Journal of the American College of Cardiology.

[3]  Yuejin Yang,et al.  Nicorandil reduces myocardial no-reflow by protection of endothelial function via the activation of KATP channel. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[4]  A. Youssef,et al.  Impact of PercuSurge device conjugative with intracoronary administration of nitroprusside on no-reflow phenomenon following primary percutaneous coronary intervention. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[5]  Zhiwei Wu,et al.  Anti-apoptotic role for C1 inhibitor in ischemia/reperfusion-induced myocardial cell injury. , 2006, Biochemical and biophysical research communications.

[6]  E. Braunwald,et al.  Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfu , 2006, American heart journal.

[7]  T. Nakano,et al.  Impact of nicorandil to prevent reperfusion injury in patients with acute myocardial infarction: Sigmart Multicenter Angioplasty Revascularization Trial (SMART). , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[8]  E. Lonn,et al.  Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. , 2006, European heart journal.

[9]  T. Celik,et al.  Impact of metabolic syndrome on myocardial perfusion grade after primary percutaneous coronary intervention in patients with acute ST elevation myocardial infarction , 2006, Coronary artery disease.

[10]  U. Sechtem,et al.  Transient left ventricular dysfunction with apical ballooning (tako–tsubo cardiomyopathy) in Germany , 2006, Clinical Research in Cardiology.

[11]  Koichi Inoue,et al.  Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction. , 2006, European heart journal.

[12]  T. L. Pinto,et al.  Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. , 2006, Cardiovascular revascularization medicine : including molecular interventions.

[13]  J. Cigarroa,et al.  Infarct-related coronary artery patency and medication use prior to ST-segment elevation myocardial infarction. , 2006, The American journal of cardiology.

[14]  I. Bilic,et al.  [Pathophysiology of ischaemia-reperfusion injury]. , 2006, Lijecnicki vjesnik.

[15]  S. Solomon,et al.  Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[16]  J. Herrmann Peri-procedural myocardial injury: 2005 update. , 2005, European heart journal.

[17]  S. Iliceto,et al.  Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: a study performed with contrast-enhanced magnetic resonance. , 2005, Journal of the American College of Cardiology.

[18]  G. Finet,et al.  Postconditioning the Human Heart , 2005, Circulation.

[19]  F. Crea,et al.  Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease. , 2005, European heart journal.

[20]  H. Matsubara,et al.  Assessment of Takotsubo cardiomyopathy (transient left ventricular apical ballooning) using99mTc-tetrofosmin,123I-BMIPP,123I-MIBG and99mTc-PYP myocardial SPECT , 2005, Annals of nuclear medicine.

[21]  M. Hori,et al.  Distal Protection Improved Reperfusion and Reduced Left Ventricular Dysfunction in Patients With Acute Myocardial Infarction Who Had Angioscopically Defined Ruptured Plaque , 2005, Circulation.

[22]  A. Avogaro,et al.  Postprandial Myocardial Perfusion in Healthy Subjects and in Type 2 Diabetic Patients , 2005, Circulation.

[23]  B. Gersh,et al.  Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction. , 2005, European heart journal.

[24]  M. Hersberger,et al.  Inflammatory Markers at the Site of Ruptured Plaque in Acute Myocardial Infarction: Locally Increased Interleukin-6 and Serum Amyloid A but Decreased C-Reactive Protein , 2005, Circulation.

[25]  B. Gersh,et al.  Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction. , 2005, Journal of the American College of Cardiology.

[26]  A. Zeiher,et al.  Endothelial Function: Cardiac Events , 2005, Circulation.

[27]  Hiroshi Ito,et al.  Detection of embolic particles with the Doppler guide wire during coronary intervention in patients with acute myocardial infarction: efficacy of distal protection device. , 2005, Journal of the American College of Cardiology.

[28]  T. Yamaki,et al.  A case of recurrent chest pain with reversible left ventricular dysfunction and ST segment elevation on electrocardiogram. , 2005, International heart journal.

[29]  A. Lerman,et al.  Systematic Review: Transient Left Ventricular Apical Ballooning: A Syndrome That Mimics ST-Segment Elevation Myocardial Infarction , 2004, Annals of Internal Medicine.

[30]  H. Matsubara,et al.  Ampulla ('takotsubo') cardiomyopathy of both ventricles: evaluation of microcirculation disturbance using 99mTc-tetrofosmin myocardial single photon emission computed tomography and doppler guide wire. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[31]  K. Eagle,et al.  Comparison of outcomes in acute coronary syndrome in patients receiving statins within 24 hours of onset versus at later times. , 2004, The American journal of cardiology.

[32]  H. Matsubara,et al.  Ampulla (`Takotsubo') Cardiomyopathy of Both Ventricles , 2004 .

[33]  John O. Prior,et al.  Chronic Inflammation and Impaired Coronary Vasoreactivity in Patients With Coronary Risk Factors , 2004, Circulation.

[34]  A. Zeiher,et al.  Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome , 2004, Coronary artery disease.

[35]  A. Jaffe,et al.  Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome. , 2004, The American journal of cardiology.

[36]  G. Lamas,et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.

[37]  R. Bolli,et al.  Myocardial Protection at a Crossroads: The Need for Translation Into Clinical Therapy , 2004, Circulation research.

[38]  Hiroshi Sato,et al.  The decrease of plaque volume during percutaneous coronary intervention has a negative impact on coronary flow in acute myocardial infarction: a major role of percutaneous coronary intervention-induced embolization. , 2004, Journal of the American College of Cardiology.

[39]  G. Heusch Coronary microembolization*1 , 2004 .

[40]  J. Waller,et al.  Mortality in Patients With Microvascular Disease , 2004, Journal of clinical hypertension.

[41]  J. Gore,et al.  Association of Statin Therapy with Outcomes of Acute Coronary Syndromes: The GRACE Study , 2004, Annals of Internal Medicine.

[42]  G. Parodi,et al.  Impact of Microvascular Dysfunction on Left Ventricular Remodeling and Long-Term Clinical Outcome After Primary Coronary Angioplasty for Acute Myocardial Infarction , 2004, Circulation.

[43]  Ori Ben-Yehuda,et al.  Effects of glycoprotein IIb/IIIa inhibition on microvascular flow after coronary reperfusion. A quantitative myocardial contrast echocardiography study. , 2004, Journal of the American College of Cardiology.

[44]  C. Cannon,et al.  The Open Artery Hypothesis: Past, Present, and Future , 1998, Journal of Thrombosis and Thrombolysis.

[45]  E. Boerwinkle,et al.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. , 2003, Circulation.

[46]  Antonio Colombo,et al.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. , 2003, Circulation.

[47]  T. Meinertz,et al.  Platelet Glycoprotein IIb/IIIa Receptor Blockade Improves Vascular Nitric Oxide Bioavailability in Patients With Coronary Artery Disease , 2003, Circulation.

[48]  R. Guyton,et al.  Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. , 2003, American journal of physiology. Heart and circulatory physiology.

[49]  K. Nishioka,et al.  Diabetes mellitus is associated with insufficient microvascular reperfusion following revascularization for anterior acute myocardial infarction. , 2003, Internal medicine.

[50]  P. Modesti,et al.  Immunomediated and Ischemia-Independent Inflammation of Coronary Microvessels in Unstable Angina , 2003, Circulation research.

[51]  J. Dubois-Randé,et al.  Incomplete Resolution of ST-Segment Elevation Is a Marker of Transient Microcirculatory Dysfunction After Stenting for Acute Myocardial Infarction , 2003, Circulation.

[52]  K. Kario,et al.  Disasters and the heart: a review of the effects of earthquake-induced stress on cardiovascular disease. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

[53]  H. Sugihara,et al.  Assessment ofTakotsubo (ampulla) cardiomyopathy using99mTc-tetrofosmin myocardial SPECT —Comparison with acute coronary syndrome— , 2003, Annals of nuclear medicine.

[54]  R. Kloner,et al.  Is microvascular protection by cariporide and ischemic preconditioning causally linked to myocardial salvage? , 2003, American journal of physiology. Heart and circulatory physiology.

[55]  F. Crea,et al.  Widespread coronary inflammation in unstable angina. , 2003, The New England journal of medicine.

[56]  R. Erbel,et al.  Preprocedural Statin Medication Reduces the Extent of Periprocedural Non–Q-Wave Myocardial Infarction , 2002, Circulation.

[57]  K. Stokes,et al.  Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. , 2002, Free radical biology & medicine.

[58]  E. Antman,et al.  Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy. , 2002, American heart journal.

[59]  Akiko Maehara,et al.  Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. , 2002, Journal of the American College of Cardiology.

[60]  G Finet,et al.  Multiple Atherosclerotic Plaque Rupture in Acute Coronary Syndrome: A Three-Vessel Intravascular Ultrasound Study , 2002, Circulation.

[61]  L. Lerman,et al.  Simvastatin preserves myocardial perfusion and coronary microvascular permeability in experimental hypercholesterolemia independent of lipid lowering. , 2002, Journal of the American College of Cardiology.

[62]  M. Graham,et al.  Abciximab Attenuates Coronary Microvascular Endothelial Dysfunction After Coronary Stenting , 2002, Circulation.

[63]  A. Giusti,et al.  Early recovery of microvascular perfusion induced by t-PA in combination with abciximab or eptifibatide during postischemic reperfusion , 2002, BMC cardiovascular disorders.

[64]  G. Maurer,et al.  Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque. , 2002, Blood.

[65]  P. Serruys,et al.  Coronary Flow Velocity Reserve After Percutaneous Interventions Is Predictive of Periprocedural Outcome , 2002, Circulation.

[66]  J. J. Griffin,et al.  Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. , 2002, The New England journal of medicine.

[67]  H. White,et al.  Withdrawal of Statins Increases Event Rates in Patients With Acute Coronary Syndromes , 2002, Circulation.

[68]  H. White,et al.  Early ST-segment recovery, infarct artery blood flow, and long-term outcome after acute myocardial infarction. , 2002, American heart journal.

[69]  R. Kloner,et al.  The “no-reflow” phenomenon: basic science and clinical correlates , 2002, Heart.

[70]  Andrew J Taylor,et al.  Experimental Rupture of Atherosclerotic Lesions Increases Distal Vascular Resistance: A Limiting Factor to the Success of Infarct Angioplasty , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[71]  U. Laufs,et al.  Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men. , 2001, The American journal of cardiology.

[72]  P. Ganz,et al.  Role of Endothelin-1 in the Active Constriction of Human Atherosclerotic Coronary Arteries , 2001, Circulation.

[73]  K. Ranjadayalan,et al.  Angiotensin-converting enzyme inhibition is associated with reduced troponin release in non-ST-elevation acute coronary syndromes. , 2001, Journal of the American College of Cardiology.

[74]  H. Sugihara,et al.  Assessment of ampulla (Takotsubo) cardiomyopathy with coronary angiography, two-dimensional echocardiography and99mTc-tetrofosmin myocardial single photon emission computed tomography , 2001, Annals of nuclear medicine.

[75]  A. Stephanou,et al.  Apoptosis of Endothelial Cells Precedes Myocyte Cell Apoptosis in Ischemia/Reperfusion Injury , 2001, Circulation.

[76]  H. Ogawa,et al.  Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. Angina Pectoris-Myocardial Infarction Investigations in Japan. , 2001, Journal of the American College of Cardiology.

[77]  L. Becker,et al.  Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia. , 2001, American journal of physiology. Heart and circulatory physiology.

[78]  A. Schmermund,et al.  Abnormal Coronary Flow Velocity Reserve After Coronary Intervention Is Associated With Cardiac Marker Elevation , 2001, Circulation.

[79]  V. Fuster,et al.  Coronary artery disease: pathogenesis and acute coronary syndromes. , 2001, The Mount Sinai journal of medicine, New York.

[80]  M. Kern,et al.  The coronary no-reflow phenomenon: a review of mechanisms and therapies. , 2001, European heart journal.

[81]  A. Lerman,et al.  The endothelium: Dysfunction and beyond , 2001, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[82]  Renu Virmani,et al.  Healed Plaque Ruptures and Sudden Coronary Death: Evidence That Subclinical Rupture Has a Role in Plaque Progression , 2001, Circulation.

[83]  A. Dart,et al.  Diurnal Variation in Endothelium-Dependent Vasodilatation Is Not Apparent in Coronary Artery Disease , 2001, Circulation.

[84]  H. Ogawa,et al.  Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. Angina Pectoris-Myocardial Infarction Investigations in Japan. , 2001, Journal of the American College of Cardiology.

[85]  R. Erbel,et al.  Coronary microembolization. , 2001, Progress in cardiovascular diseases.

[86]  R. Califf,et al.  Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. , 2001, Journal of the American College of Cardiology.

[87]  MasanoriKawasaki,et al.  Considerable Time From the Onset of Plaque Rupture and/or Thrombi Until the Onset of Acute Myocardial Infarction in Humans , 2000 .

[88]  T Suzuki,et al.  Considerable Time From the Onset of Plaque Rupture and/or Thrombi Until the Onset of Acute Myocardial Infarction in Humans: Coronary Angiographic Findings Within 1 Week Before the Onset of Infarction , 2000, Circulation.

[89]  K. Okumura,et al.  Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. , 2000, Journal of the American College of Cardiology.

[90]  I. Tsuji,et al.  Increased acute myocardial infarction mortality following the 1995 Great Hanshin-Awaji earthquake in Japan. , 2000, International journal of epidemiology.

[91]  R. Testa,et al.  Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. , 2000, Circulation.

[92]  H. White,et al.  ST-Segment recovery adds to the assessment of TIMI 2 and 3 flow in predicting infarct wall motion after thrombolytic therapy. , 2000, Circulation.

[93]  S. Higano,et al.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.

[94]  J. Freyssinet,et al.  Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. , 2000, Circulation.

[95]  A. L'Abbate,et al.  Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina. , 2000, Journal of the American College of Cardiology.

[96]  C M Gibson,et al.  Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. , 2000, Circulation.

[97]  C. Heeschen,et al.  Angiographic findings in patients with refractory unstable angina according to troponin T status. , 1999, Circulation.

[98]  M J Davies,et al.  Mechanisms of progression in native coronary artery disease: role of healed plaque disruption , 1999, Heart.

[99]  R. Califf,et al.  Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. , 1999, Circulation.

[100]  J. Viikari,et al.  Early impairment of coronary flow reserve in young men with borderline hypertension. , 1998, Journal of the American College of Cardiology.

[101]  L. Matis,et al.  Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. , 1998, Circulation.

[102]  Katherine C. Wu,et al.  Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. , 1998, Circulation.

[103]  T. Lehtimäki,et al.  Coronary Flow Reserve Is Reduced in Young Men With IDDM , 1998, Diabetes.

[104]  M. Kozáková,et al.  Mechanisms of coronary flow reserve impairment in human hypertension. An integrated approach by transthoracic and transesophageal echocardiography. , 1997, Hypertension.

[105]  W. Edwards,et al.  Mechanical pressure and stretch release endothelin-1 from human atherosclerotic coronary arteries in vivo. , 1997, Circulation.

[106]  J. Viikari,et al.  Coronary flow reserve is impaired in young men with familial hypercholesterolemia. , 1996, Journal of the American College of Cardiology.

[107]  K. Bailey,et al.  Coronary embolization after balloon angioplasty or thrombolytic therapy: an autopsy study of 32 cases. , 1993, Journal of the American College of Cardiology.

[108]  M. Chiariello,et al.  The effects of calcium channel antagonist treatment and oxygen radical scavenging on infarct size and the no-reflow phenomenon in reperfused hearts. , 1993, American heart journal.

[109]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[110]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (1). , 1992, The New England journal of medicine.

[111]  J. Folts An in vivo model of experimental arterial stenosis, intimal damage, and periodic thrombosis. , 1991, Circulation.

[112]  M. Ishihara,et al.  [Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases]. , 1991, Journal of cardiology.

[113]  R. Bolli,et al.  Prolonged impairment of coronary vasodilation after reversible ischemia. Evidence for microvascular "stunning". , 1990, Circulation research.

[114]  L. Becker,et al.  Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. , 1989, Circulation.

[115]  C. White,et al.  INTENSE MICROVASCULAR CONSTRICTION AFTER ANGIOPLASTY OF ACUTE THROMBOTIC CORONARY ARTERIAL LESIONS , 1989, The Lancet.

[116]  R. Virmani,et al.  Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. , 1987, Circulation.

[117]  M. Hori,et al.  Role of adenosine in hyperemic response of coronary blood flow in microembolization. , 1986, The American journal of physiology.

[118]  E. Falk Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. , 1985, Circulation.

[119]  Richard J. Jones Heart Disease: A Textbook of Cardiovascular Medicine , 1980 .

[120]  E. Braunwald,et al.  Ultrastructural Evidence of Microvascular Damage and Myocardial Cell Injury After Coronary Artery Occlusion: Which Comes First? , 1980, Circulation.

[121]  E. Braunwald Heart Disease: A Textbook of Cardiovascular Medicine , 1992, Annals of Internal Medicine.

[122]  W. Roberts Coronary Thrombosis and Fatal Myocardial Ischemia , 1974 .

[123]  W. Roberts Editorial: Coronary thrombosis and fatal myocardial ischemia. , 1974, Circulation.